Previous Article | Next Article 
Infection and Immunity, November 2004, p. 6492-6502, Vol. 72, No. 11
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.11.6492-6502.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Antibodies to the N-Terminal Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Associated with Protection against Clinical Malaria
David R. Cavanagh,1*
Daniel Dodoo,2
Lars Hviid,3
Jørgen A. L. Kurtzhals,3
Thor G. Theander,3
Bartholomew D. Akanmori,2
Spencer Polley,4
David J. Conway,4
Kojo Koram,2 and
Jana S. McBride1
Institute of Cell, Animal and Population Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, Scotland,1
London School of Hygiene and Tropical Medicine, London, United Kingdom,4
Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana,2
Centre for Medical Parasitology at the Department of Infectious Diseases and Department of Clinical Microbiology, Copenhagen University Hospital (Rigshospitalet) and at the Institute for Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark3
Received 10 February 2004/
Returned for modification 19 March 2004/
Accepted 26 July 2004
This longitudinal prospective study shows that antibodies to the N-terminal block 2 region of the Plasmodium falciparum merozoite surface protein 1 (MSP-1) are associated with protection against clinical malaria in an area of stable but seasonal malaria transmission of Ghana. Antibodies to the block 2 region of MSP-1 were measured in a cohort of 280 children before the beginning of the major malaria transmission season. The cohort was then actively monitored for malaria, clinically and parasitologically, over a period of 17 months. Evidence is presented for an association between antibody responses to block 2 and a significantly reduced risk of subsequent clinical malaria. Furthermore, statistical survival analysis provides new information on the duration of the effect over time. The results support a conclusion that the block 2 region of MSP-1 is a target of protective immunity against P. falciparum and, thus, a promising new candidate for the development of a malaria vaccine.
* Corresponding author. Mailing address: Institute of Cell, Animal and Population Biology, School of Biological Sciences, University of Edinburgh, King's Buildings, West Mains Rd., Edinburgh EH9 3JT, Scotland, United Kingdom. Phone: 44 131 650 5459. Fax: 44 131 650 7322. E-mail: david.cavanagh{at}ed.ac.uk.
Editor: S. H. E. Kaufmann
Infection and Immunity, November 2004, p. 6492-6502, Vol. 72, No. 11
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.11.6492-6502.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Osier, F. H. A., Fegan, G., Polley, S. D., Murungi, L., Verra, F., Tetteh, K. K. A., Lowe, B., Mwangi, T., Bull, P. C., Thomas, A. W., Cavanagh, D. R., McBride, J. S., Lanar, D. E., Mackinnon, M. J., Conway, D. J., Marsh, K.
(2008). Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria. Infect. Immun.
76: 2240-2248
[Abstract]
[Full Text]
-
Nebie, I., Diarra, A., Ouedraogo, A., Soulama, I., Bougouma, E. C., Tiono, A. B., Konate, A. T., Chilengi, R., Theisen, M., Dodoo, D., Remarque, E., Bosomprah, S., Milligan, P., Sirima, S. B.
(2008). Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal Malaria Transmission in Burkina Faso, West Africa. Infect. Immun.
76: 759-766
[Abstract]
[Full Text]
-
Gray, J. C., Corran, P. H., Mangia, E., Gaunt, M. W., Li, Q., Tetteh, K. K.A., Polley, S. D., Conway, D. J., Holder, A. A., Bacarese-Hamilton, T., Riley, E. M., Crisanti, A.
(2007). Profiling the Antibody Immune Response against Blood Stage Malaria Vaccine Candidates. Clin. Chem.
53: 1244-1253
[Abstract]
[Full Text]
-
Conway, D. J.
(2007). Molecular Epidemiology of Malaria. Clin. Microbiol. Rev.
20: 188-204
[Abstract]
[Full Text]
-
Nogueira, P. A., Piovesan Alves, F., Fernandez-Becerra, C., Pein, O., Rodrigues Santos, N., Pereira da Silva, L. H., Plessman Camargo, E., del Portillo, H. A.
(2006). A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1.. Infect. Immun.
74: 2726-2733
[Abstract]
[Full Text]
-
Lusingu, J. P. A., Jensen, A. T. R., Vestergaard, L. S., Minja, D. T., Dalgaard, M. B., Gesase, S., Mmbando, B. P., Kitua, A. Y., Lemnge, M. M., Cavanagh, D., Hviid, L., Theander, T. G.
(2006). Levels of Plasma Immunoglobulin G with Specificity against the Cysteine-Rich Interdomain Regions of a Semiconserved Plasmodium falciparum Erythrocyte Membrane Protein 1, VAR4, Predict Protection against Malarial Anemia and Febrile Episodes.. Infect. Immun.
74: 2867-2875
[Abstract]
[Full Text]
-
Woehlbier, U., Epp, C., Kauth, C. W., Lutz, R., Long, C. A., Coulibaly, B., Kouyate, B., Arevalo-Herrera, M., Herrera, S., Bujard, H.
(2006). Analysis of Antibodies Directed against Merozoite Surface Protein 1 of the Human Malaria Parasite Plasmodium falciparum. Infect. Immun.
74: 1313-1322
[Abstract]
[Full Text]
-
Tongren, J. E., Drakeley, C. J., McDonald, S. L. R., Reyburn, H. G., Manjurano, A., Nkya, W. M. M., Lemnge, M. M., Gowda, C. D., Todd, J. E., Corran, P. H., Riley, E. M.
(2006). Target Antigen, Age, and Duration of Antigen Exposure Independently Regulate Immunoglobulin G Subclass Switching in Malaria. Infect. Immun.
74: 257-264
[Abstract]
[Full Text]
-
Tongren, J. E., Corran, P. H., Jarra, W., Langhorne, J., Riley, E. M.
(2005). Epitope-Specific Regulation of Immunoglobulin Class Switching in Mice Immunized with Malarial Merozoite Surface Proteins. Infect. Immun.
73: 8119-8129
[Abstract]
[Full Text]
-
Tetteh, K. K. A., Cavanagh, D. R., Corran, P., Musonda, R., McBride, J. S., Conway, D. J.
(2005). Extensive Antigenic Polymorphism within the Repeat Sequence of the Plasmodium falciparum Merozoite Surface Protein 1 Block 2 Is Incorporated in a Minimal Polyvalent Immunogen. Infect. Immun.
73: 5928-5935
[Abstract]
[Full Text]
-
JOHN, C. C., MOORMANN, A. M., PREGIBON, D. C., SUMBA, P. O., MCHUGH, M. M., NARUM, D. L., LANAR, D. E., SCHLUCHTER, M. D., KAZURA, J. W.
(2005). CORRELATION OF HIGH LEVELS OF ANTIBODIES TO MULTIPLE PRE-ERYTHROCYTIC PLASMODIUM FALCIPARUM ANTIGENS AND PROTECTION FROM INFECTION. Am J Trop Med Hyg
73: 222-228
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.